enVVeno Medical Corporation (NVNO)
$11.05
$-0.05
(-0.45%)
As on 04-Sep-2026 11:39EDT
Market cap
$7 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-512.8
-
Face value
--
-
Shares outstanding
694,826
9 Years Aggregate
CFO
$-75.56 Mln
EBITDA
$-102.30 Mln
Net Profit
$-106.39 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
enVVeno Medical (NVNO)
| -1.6 | 3.3 | 3.2 | -59.5 | -60.2 | -47.7 | -- |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
enVVeno Medical (NVNO)
| -89.4 | -41.0 | 0.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
enVVeno Medical (NVNO)
|
11.1 | 7.5 | 0.0 | -15.7 | -- | -65.8 | -- | 0.4 |
| 84.8 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 268.4 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 72.4 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 59.0 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 110.2 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 355.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 118.2 | 9,718.7 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.6 | |
| 541.4 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 592.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 |
Shareholding Pattern
View DetailsAbout enVVeno Medical (NVNO)
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the... VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Read more
-
CEO & Director
Mr. Robert A. Berman
-
CEO & Director
Mr. Robert A. Berman
-
Headquarters
Irvine, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for enVVeno Medical (NVNO)
What is the current share price of enVVeno Medical Corporation (NVNO) Today?
The share price of enVVeno Medical Corporation (NVNO) is $11.05 (NASDAQ) as of 04-Sep-2026 11:39 EDT. enVVeno Medical Corporation (NVNO) has given a return of -60.18% in the last 3 years.
What is the current PB & PE ratio of enVVeno Medical Corporation (NVNO)?
Since, TTM earnings of enVVeno Medical Corporation (NVNO) is negative, P/E ratio is not available.
The P/B ratio of enVVeno Medical Corporation (NVNO) is 0.38 times as on 28-Aug-2026, a 93 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of enVVeno Medical Corporation (NVNO)?
The 52-week high and low of enVVeno Medical Corporation (NVNO) are Rs 35.70 and Rs 8.67 as of 06-Sep-2026.
What is the market cap of enVVeno Medical Corporation (NVNO)?
enVVeno Medical Corporation (NVNO) has a market capitalisation of $ 7 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in enVVeno Medical Corporation (NVNO)?
Before investing in enVVeno Medical Corporation (NVNO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.